TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA
72 insider filings · Latest: Sep 19, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 | Jun 3 7:59 PM | Shields Matthew | Proposed Sale | 16,195 | $32.87 | $532.3K | — | View → |
| May 14, 2026 | May 18 8:02 PM | Evan LippmanEVP, Business Development | Sale | 41,658 | $35.58 | $1.5M | 44,191(D) | View → |
| May 14, 2026 | May 18 8:00 PM | Eliyahu Sharon KalifEVP, Chief Financial Officer | Sale | 153,251 | $35.61 | $5.5M | 172,184(D) | View → |
| May 14, 2026 | May 14 8:02 PM | Lippman Evan | Proposed Sale | 41,658 | $35.58 | $1.5M | — | View → |
| May 14, 2026 | May 14 7:59 PM | Kalif Eliyahu Sharon | Proposed Sale | 153,251 | $35.61 | $5.5M | — | View → |
| May 6, 2026 | May 7 8:03 PM | Amir WeissChief Accounting Officer | Sale | 10,679 | $36.00 | $384.4K | 20,016(D) | View → |
| May 5, 2026 | May 7 8:01 PM | Richard DaniellEVP, Europe Commercial | Sale | 30,000 | $35.40 | $1.1M | 55,755(D) | View → |
| May 5, 2026 | May 5 8:00 PM | Daniell Richard | Proposed Sale | 30,000 | $35.40 | $1.1M | — | View → |
| May 1, 2026 | May 4 8:02 PM | Mark SabagSee "Remarks" | Sale | 144,180 | $34.99 | $5.0M | 80,760(D) | View → |
| Apr 30, 2026 | May 4 8:00 PM | Christine FoxEVP, U.S. Commercial | Sale | 21,258 | $35.31 | $750.6K | 63,647(D) | View → |
| May 1, 2026 | May 4 12:12 PM | Sabag Mark | Proposed Sale | 144,180 | $34.99 | $5.0M | — | View → |
| Apr 30, 2026 | Apr 30 8:40 PM | Christine Fox | Proposed Sale | 21,258 | $35.31 | $750.6K | — | View → |
| Mar 17, 2026 | Mar 19 8:01 PM | Mark SabagSee "Remarks" | Sale | 62,102 | $30.14 | $1.9M | 224,940(D) | View → |
| Mar 17, 2026 | Mar 17 8:15 PM | Sabag Mark | Proposed Sale | 62,102 | $30.14 | $1.9M | — | View → |
| Mar 5, 2026 | Mar 9 8:18 PM | Richard D FrancisPresident and CEO | Sale | 20,025 | $31.67 | $634.2K | 1,170,639(D) | View → |
| Mar 5, 2026 | Mar 9 8:16 PM | Christine FoxEVP, U.S. Commercial | Sale | 7,924 | $31.67 | $250.9K | 84,905(D) | View → |
| Mar 5, 2026 | Mar 9 8:14 PM | Eric A HughesSee "Remarks" | Sale | 9,533 | $31.67 | $301.9K | 107,711(D) | View → |
| Mar 5, 2026 | Mar 9 8:12 PM | Richard DaniellEVP, Europe Commercial | Sale | 17,295 | $31.67 | $547.7K | 85,755(D) | View → |
| Mar 5, 2026 | Mar 9 8:10 PM | Placid JoverSee "Remarks" | Sale | 14,150 | $31.67 | $448.1K | 6,774(D) | View → |
| Mar 5, 2026 | Mar 9 8:09 PM | Brian SavageInterim Chief Legal Officer | Sale | 1,127 | $31.67 | $35.7K | 10,914(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | Mar 5 9:01 PM | Eric A HughesSee "Remarks" | Option Exercise | 166,378 | — | 0(D) | View → |
| Feb 15, 2026 | Feb 18 9:01 PM | Richard D FrancisPresident and CEO | Option Exercise | 781,766 | — | 0(D) | View → |
| Jan 27, 2026 | Jan 29 9:07 PM | Eliyahu Sharon KalifEVP, Chief Financial Officer | Grant/Award | 141,478 | — | 141,478(D) | View → |
| Jan 27, 2026 | Jan 29 9:05 PM | Eric A HughesSee "Remarks" | Grant/Award | 141,478 | — | 141,478(D) | View → |
| Jan 27, 2026 | Jan 29 9:04 PM | Mark SabagSee "Remarks" | Grant/Award | 141,478 | — | 141,478(D) | View → |
| Jan 27, 2026 | Jan 29 9:02 PM | Richard DaniellExec. VP, European Commercial | Grant/Award | 141,478 | — | 141,478(D) | View → |
| Jan 27, 2026 | Jan 29 9:01 PM | Richard D FrancisPresident and CEO | Grant/Award | 1,511,425 | — | 891,315(D) | View → |
← Previous
Page 4 of 4